176 related articles for article (PubMed ID: 23025913)
1. Staying ahead of viruses: a never ending task.
Lamarre D; Wainberg MA
Curr Opin Virol; 2012 Oct; 2(5):569-71. PubMed ID: 23025913
[No Abstract] [Full Text] [Related]
2. The program of antiviral agents inhibits virus infection.
Ding YZ; Lv JL; Zhang ZW; Ma XY; Zhang J; Zhang YG
Arch Microbiol; 2018 Aug; 200(6):841-846. PubMed ID: 29846759
[TBL] [Abstract][Full Text] [Related]
3. RNA interference & inhibition of viruses.
Gadkari DA
Indian J Med Res; 2005 Mar; 121(3):147-50. PubMed ID: 15802755
[No Abstract] [Full Text] [Related]
4. Broad-Spectrum Antivirals and Antiviral Drug Combinations.
Oksenych V; Kainov DE
Viruses; 2022 Feb; 14(2):. PubMed ID: 35215894
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of virus assembly.
Perlmutter JD; Hagan MF
Annu Rev Phys Chem; 2015 Apr; 66():217-39. PubMed ID: 25532951
[TBL] [Abstract][Full Text] [Related]
6. Editorial overview: Antiviral strategies: Antiviral drug design: creating new ideas against old and new bugs.
Naesens L; Zoulim F
Curr Opin Virol; 2017 Jun; 24():v-vii. PubMed ID: 28743435
[No Abstract] [Full Text] [Related]
7. Human- and virus-encoded microRNAs as potential targets of antiviral therapy.
Kurzyńska-Kokorniak A; Jackowiak P; Figlerowicz M; Figlerowicz M
Mini Rev Med Chem; 2009 Jul; 9(8):927-37. PubMed ID: 19601888
[TBL] [Abstract][Full Text] [Related]
8. Editorial overview: antivirals and resistance: advances and challenges ahead.
Menéndez-Arias L; Richman DD
Curr Opin Virol; 2014 Oct; 8():iv-vii. PubMed ID: 25155454
[No Abstract] [Full Text] [Related]
9. Human viral diseases: what is next for antiviral drug discovery?
De Clercq E
Curr Opin Virol; 2012 Oct; 2(5):572-9. PubMed ID: 22846888
[TBL] [Abstract][Full Text] [Related]
10. Meeting report: 26th International Conference on Antiviral Research.
Vere Hodge RA
Antiviral Res; 2013 Oct; 100(1):276-85. PubMed ID: 23973733
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic Potential of Spirooxindoles as Antiviral Agents.
Ye N; Chen H; Wold EA; Shi PY; Zhou J
ACS Infect Dis; 2016 Jun; 2(6):382-92. PubMed ID: 27627626
[TBL] [Abstract][Full Text] [Related]
12. Editorial overview: Engineering for viral resistance.
von Brunn A
Curr Opin Virol; 2015 Oct; 14():v-vii. PubMed ID: 26320757
[No Abstract] [Full Text] [Related]
13. Antiviral Strategies Based on Lethal Mutagenesis and Error Threshold.
Perales C; Domingo E
Curr Top Microbiol Immunol; 2016; 392():323-39. PubMed ID: 26294225
[TBL] [Abstract][Full Text] [Related]
14. Carbazole Derivatives as Antiviral Agents: An Overview.
Caruso A; Ceramella J; Iacopetta D; Saturnino C; Mauro MV; Bruno R; Aquaro S; Sinicropi MS
Molecules; 2019 May; 24(10):. PubMed ID: 31109016
[No Abstract] [Full Text] [Related]
15. [The antiviral activity of chitosan (review)].
Chirkov SN
Prikl Biokhim Mikrobiol; 2002; 38(1):5-13. PubMed ID: 11852567
[TBL] [Abstract][Full Text] [Related]
16. What is the antiviral potential of pyrrole-imidazole polyamides?
He G; Bashkin JK
Future Med Chem; 2015; 7(15):1953-5. PubMed ID: 26496156
[No Abstract] [Full Text] [Related]
17. Lethal mutagenesis of viruses.
Perales C; Martín V; Domingo E
Curr Opin Virol; 2011 Nov; 1(5):419-22. PubMed ID: 22440845
[TBL] [Abstract][Full Text] [Related]
18. [Prospects of studying the antiviral properties of cytokines].
Votiakov VI; Gribkova NV
Antibiot Khimioter; 1990 Oct; 35(10):13-8. PubMed ID: 1703757
[No Abstract] [Full Text] [Related]
19. Application of modified antisense oligonucleotides and siRNAs as antiviral drugs.
Wagner A; Bock CT; Fechner H; Kurreck J
Future Med Chem; 2015; 7(13):1637-42. PubMed ID: 26381598
[No Abstract] [Full Text] [Related]
20. New horizons for antiviral drug discovery from virus-host protein interaction networks.
de Chassey B; Meyniel-Schicklin L; Aublin-Gex A; André P; Lotteau V
Curr Opin Virol; 2012 Oct; 2(5):606-13. PubMed ID: 23025912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
